Long-term administration of Tolvaptan to patients with decompensated cirrhosis

Aim: Tolvaptan, an oral vasopressin-2 antagonist, sometimes improves hepatic edema including ascites in patients with decompensated cirrhosis. In this study, we examined the effectiveness and survival advantage in patients with the long-term administration of tolvaptan. Methods: A total of 115 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanayama, Kengo, Chiba, Tetsuhiro, Kobayashi, Kazufumi, Koroki, Keisuke, Maruta, Susumu, Kanzaki, Hiroaki, Kusakabe, Yuko, Saito, Tomoko, Kiyono, Soichiro, Nakamura, Masato, Ogasawara, Sadahisa, Suzuki, Eiichiro, Ooka, Yoshihiko, Nakamoto, Shingo, Yasui, Shin, Kanda, Tatsuo, Maruyama, Hitoshi, Kato, Jun, Kato, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163362/
https://www.ncbi.nlm.nih.gov/pubmed/32308540
http://dx.doi.org/10.7150/ijms.41454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163362/
https://www.ncbi.nlm.nih.gov/pubmed/32308540
http://dx.doi.org/10.7150/ijms.41454

Ejemplares similares